다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Nutrients, v.6 no.2, 2014년, pp.799 - 814
von Schacky, Clemens (Preventive Cardiology, Medical Clinic and Poli-Clinic I, Ludwig Maximilians-University Munich, Ziemssenstr. 1, Munich 80336, Germany)
AI-Helper
Recent large trials with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the cardiovascular field did not demonstrate a beneficial effect in terms of reductions of clinical endpoints like total mortality, sudden cardiac arrest or other major adverse cardiac events. Pertinent guidelines...
1. Burr M.L. Fehily A.M. Gilbert J.F. Rogers S. Holliday R.M. Sweetnam P.M. Elwood P.C. Deadman N.M. Effects of changes in fat, fish, and fibre intakes on death and myocardial infarction: Diet and reinfarction trial (DART) Lancet 1989 2 757 761 2571009
2. GISSI Prevenzione Investigators Dietary supplementation with n -3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico Lancet 1999 354 447 455 10.1016/S0140-6736(99)07072-5 10465168
3. Marchioli R. Barzi F. Bomba E. Chieffo C. di Gregorio D.D.M.R. Franzosi M.G. Geraci E. Levatesi G. Maggioni A.P. Mantini L. Early protection against sudden death by n -3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarcto Miocardio (GISSI)-Prevenzione Circulation 2002 105 1897 1903 10.1161/01.CIR.0000014682.14181.F2 11997274
4. Svensson M. Schmidt E.B. Jørgensen K.A. Christensen J.H. OPACH Study Group n -3 Fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: A randomized, placebo-controlled intervention trial Clin. J. Am. Soc. Nephrol. 2006 1 780 786 10.2215/CJN.00630206 17699287
5. Yokoyama M. Origasa H. Matsuzaki M. Matsuzawa Y. Saito Y. Ishikawa Y. Oikawa S. Sasaki J. Hishida H. Itakura H. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis Lancet 2007 369 1090 1098 10.1016/S0140-6736(07)60527-3 17398308
6. Gissi-HF Investigators Tavazzi L. Maggioni A.P. Marchioli R. Barlera S. Franzosi M.G. Latini R. Lucci D. Nicolosi G.L. Porcu M. Effect of n -3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial Lancet 2008 372 1223 1230 10.1016/S0140-6736(08)61239-8 18757090
7. Galan P. Kesse-Guyot E. Czernichow S. Briancon S. Blacher J. Hercberg S. SU.FOL.OM3 Collaborative Group Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: A randomised placebo controlled trial Br. Med. J. 2010 341 c6273 10.1136/bmj.c6273 21115589
8. Rauch B. Schiele R. Schneider S. Diller F. Victor N. Gohlke H. Gottwik M. Steinbeck G. del Castillo U. Sack R. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 2010 122 2152 2159 10.1161/CIRCULATIONAHA.110.948562 21060071
9. Einvik G. Klemsdal T.O. Sandvik L. Hjerkinn E.M. A randomized clinical trial on n -3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk Eur. J. Cardiovasc. Prev. Rehabil. 2010 17 588 592 10.1097/HJR.0b013e328339cc70 20389249
10. Kromhout D. Giltay E.J. Geleijnse J.M. Alpha Omega Trial Group. n -3 Fatty acids and cardiovascular events after myocardial infarction N. Engl. J. Med. 2010 363 2015 2026 10.1056/NEJMoa1003603 20929341
11. ORIGIN Trial Investigators Bosch J. Gerstein H.C. Dagenais G.R. Díaz R. Dyal L. Jung H. Maggiono A.P. Probstfield J. Ramachandran A. n -3 Fatty acids and cardiovascular outcomes in patients with dysglycemia N. Engl. J. Med. 2011 367 319 328 22686416
12. Risk and Prevention Study Collaborative Group Roncaglioni M.C. Tombesi M. Avanzini F. Barlera S. Caimi V. Longoni P. Marzona I. Milani V. Silletta M.G. n -3 Fatty acids in patients with multiple cardiovascular risk factors N. Engl. J. Med. 2013 368 1800 1808 10.1056/NEJMoa1205409 23656645
13. Chowdhury R. Stevens S. Gorman D. Pan A. Warnakula S. Chowdhury S. Ward H. Johnson L. Crowe F. Hu F.B. Asociation between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis Br. Med. J. 2012 345 e6698 10.1136/bmj.e6698 23112118
14. Kotwal S. Jun M. Sullivan D. Perkovic V. Neal B. Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis Circ. Cardiovasc. Qual. Outcomes 2012 5 808 818 10.1161/CIRCOUTCOMES.112.966168 23110790
15. Rizos E.C. Ntzani E.E. Bika E. Kostapanos M.S. Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis J. Am. Med. Assoc. 2012 308 1024 1033 10.1001/2012.jama.11374
16. Kwak S.M. Myung S.K. Lee Y.J. Seo H.G. Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebo-controlled trials Arch. Intern. Med. 2012 172 686 694 10.1001/archinternmed.2012.262 22493407
17. Delgado-Lista J. Perez-Martinez P. Lopez-Miranda J. Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: A systematic review Br. J. Nutr. 2012 107 S201 S213 10.1017/S0007114512001596 22591894
18. Mozaffarian D. Rimm E.B. Fish intake, contaminants, and human health: Evaluating the risks and the benefits J. Am. Med. Assoc. 2006 296 1885 1899 10.1001/jama.296.15.1885
19. Hu F.B. Bronner L. Willett W.C. Stampfer M.J. Rexrode K.M. Albert C.M. Hunter D. Manson J.E. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women J. Am. Med. Assoc. 2002 287 1815 1821 10.1001/jama.287.14.1815
20. Siscovick D.S. Raghunathan T.E. King I. Weinmann S. Wicklund K.G. Albright J. Bovbjerg V. Arbogast P. Smith H. Kushi L.H. Dietary intake and cell membrane levels of long-chain n -3 polyunsaturated fatty acids and the risk of primary cardiac arrest J. Am. Med. Assoc. 1995 275 836 837
21. Albert C.M. Campos H. Stampfer M.J. Ridker P.M. Manson J.E. Willett W.C. Ma J. Blood levels of long-chain n -3 fatty acids and the risk of sudden death N. Engl. J. Med. 2002 346 1113 1118 10.1056/NEJMoa012918 11948270
22. Smith S.C. Jr. Benjamin E.J. Bonow R.O. Braun L.T. Creager M.A. Franklin B.A. Gibbons R.J. Grundy S.M. Hiratzka L.F. Jones D.W. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 Update: A guideline from the american heart association and american college of cardiology foundation Circulation 2011 124 2458 2473 10.1161/CIR.0b013e318235eb4d 22052934
23. Perk J. de Backer G. Gohlke H. Graham I. Reiner Z. Verschuren M. Albus C. Benlian P. Boysen G. Cifkova R. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur. Heart J. 2012 33 1635 1701 10.1093/eurheartj/ehs092 22555213
24. Fihn S.D. Gardin J.M. Abrams J. Berra K. Blankenship J.C. Dallas A.P. Douglas P.S. Foody J.M. Gerber T.C. Hinderliter A.L. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American college of cardiology foundation/american heart association task force on practice guidelines, and the american college of physicians, american association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons Circulation 2012 126 e354 e471 10.1161/CIR.0b013e318277d6a0 23166211
25. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Steg P.G. James S.K. Atar D. Badano L.P. Blömstrom-Lundqvist C. Borger M.A. di Mario C. Dickstein K. Ducrocq G. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur. Heart J. 2012 33 2569 2619 22922416
26. Mozaffarian D. Psaty B.M. Rimm E.B. Lemaitre R.N. Burke G.L. Lyles M.F. Lefkowitz D. Siscovick D.S. Fish intake and risk of incident atrial fibrillation Circulation 2004 110 368 373 10.1161/01.CIR.0000138154.00779.A5 15262826
27. Wu J.H. Lemaitre R.N. King I.B. Song X. Sacks F.M. Rimm E.B. Heckbert S.R. Siscovick D.S. Mozaffarian D. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: The cardiovascular health study Circulation 2012 125 1084 1093 10.1161/CIRCULATIONAHA.111.062653 22282329
28. Mozaffarian D. Wu J.H. de Oliveira Otto M.C. Sandesara C.M. Metcalf R.G. Latini R. Libby P. Lombardi F. O’Gara P.T. Page R.L. Fish oil and post-operative atrial fibrillation: A meta-analysis of randomized controlled trials J. Am. Coll. Cardiol. 2013 61 2194 2196 10.1016/j.jacc.2013.02.045 23541970
29. European Heart Rhythm Association European Association for Cardio-Thoracic Surgery Camm A.J. Kirchhof P. Lip G.Y. Schotten U. Savelieva I. Ernst S. can Gelder I.C. Al-Attar N. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (ESC) Eur. Heart J. 2010 31 2369 2429 10.1093/eurheartj/ehq278 20802247
30. Brouwer I.A. Raitt M.H. Dullemeijer C. Kraemer D.F. Zock P.L. Morris C. Katan M.B. Connor W.E. Camm J.A. Schouten E.G. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators Eur. Heart J. 2009 30 820 826 19196720
31. Zipes D.P. Camm A.J. Borggrefe M. Buxton A.E. Chaitman B. Fromer M. Gregoratos G. Klein G. Moss A.J. Myerburg R.J. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—Executive summary: A report of the American college of cardiology/American heart association task force and the european society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European heart rhythm association and the heart rhythm society Eur. Heart J. 2006 27 2099 2140 10.1093/eurheartj/ehl199 16923744
32. Archer E. Hand G.A. Blair S.N. Validity of U.S. nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971–2010 PLoS One 2013 8 e76632 10.1371/journal.pone.0076632 24130784
33. De Oliveira Otto M.C. Wu J.H. Baylin A. Vaidya D. Rich S.S. Tsai M.Y. Jacobs D.R. Mozaffarian D. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the multi-ethnic study of atherosclerosis J. Am. Heart Assoc. 2013 2 e000506 10.1161/JAHA.113.000506 24351702
34. Harris W.S. von Schacky C. Park Y. Standardizing Methods for Assessing Omega-3 Biostatus The Omega-3 Deficiency Syndrome McNamara R.K. Nova Publishers Hauppauge, NY, USA 2013 385 398
35. Von Schacky C. Fischer S. Weber P.C. Long term effects of dietary marine omega-3 fatty acids upon plasma- and cellular lipids, platelet function and eicosanoid formation in humans J. Clin. Investig. 1985 76 1626 1631 10.1172/JCI112147 2997286
36. Harris W.S. Sands S.A. Windsor S.L. Ali H.A. Stevens T.L. Magalski A. Porter C.B. Borkon A.M. Omega-3 fatty acid levels in transplanted human hearts: Effect of supplementation and comparison with erythrocytes Circulation 2004 110 1645 1649 10.1161/01.CIR.0000142292.10048.B2 15353491
37. Arnold C. Markovic M. Blossey K. Wallukat G. Fischer R. Dechend R. Konkel A. von Schacky C. Luft F.C. Muller D.N. Arachidonic acid-metabolizing cytochrome P-450 enzymes are targets of omega-3 fatty acids J. Biol. Chem. 2010 285 32720 32733 10.1074/jbc.M110.118406 20732876
38. Harris W.S. Thomas R.M. Biological variability of blood omega-3 biomarkers Clin. Biochem. 2010 43 338 340 10.1016/j.clinbiochem.2009.08.016 19733159
39. Harris W.S. von Schacky C. The omega-3 index: A new risk factor for death from CHD? Prev. Med. 2004 39 212 220 10.1016/j.ypmed.2004.02.030 15208005
40. Hlatky M.A. Greenland P. Arnett D.K. Ballantyne C.M. Criqui M.H. Elkind M.S. Go A.S. Harrell F.E. Jr. Hong Y. Howard B.V. American heart association expert panel on subclinical atherosclerotic diseases and emerging risk factors and the stroke council Circulation 2009 119 2408 2416 10.1161/CIRCULATIONAHA.109.192278 19364974
41. Helfand M. Buckley D.I. Freeman M. Fu R. Rogers K. Fleming C. Humphrey L.L. Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. preventive services task force Ann. Intern. Med. 2009 151 496 507 10.7326/0003-4819-151-7-200910060-00010 19805772
42. Köhler A. Bittner D. Löw A. von Schacky C. Effects of a convenience drink fortified with n -3 fatty acids on the n -3 index Br. J. Nutr. 2010 104 729 736 10.1017/S0007114510001054 20420756
43. Neubronner J. Schuchardt J.P. Kressel G. Merkel M. von Schacky C. Hahn A. Enhanced increase of omega-3 index in response to long-term n -3 fatty acid supplementation from triacylglycerides vs . ethyl esters Eur. J. Clin. Nutr. 2011 65 247 254 10.1038/ejcn.2010.239 21063431
44. Baghai T.C. Varallo-Bedarida G. Born C. Häfner S. Schüle C. Eser D. Rupprecht R. Bondy B. von Schacky C. Major depression is associated with cardiovascular risk factors and low Omega-3 Index J. Clin. Psychiatry 2011 72 1242 1247 10.4088/JCP.09m05895blu 21208589
45. Sala-Vila A. Harris W.S. Cofán M. Pérez-Heras A.M. Pintó X. Lamuela-Raventós R.M. Covas M.I. Estruch R. Ros E. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD Br. J. Nutr. 2011 106 425 431 10.1017/S0007114511000171 21450116
46. Aarsetoey H. Pönitz V. Nilsen O.B. Grundt H. Harris W.S. Nilsen D.W. Low levels of cellular omega-3 increases the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction Resuscitation 2008 78 258 264 10.1016/j.resuscitation.2008.04.007 18556107
47. Sands S.A. Reid K.J. Windsor S.L. Harris W.S. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes Lipids 2005 40 343 347 10.1007/s11745-006-1392-2 16028715
48. Harris W.S. Pottala J.V. Vasan R.S. Larson M.G. Robins S.J. Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans J. Nutr. 2012 142 1297 1303 10.3945/jn.112.158295 22623386
49. Pottala J.V. Garg S. Cohen B.E. Whooley M.A. Harris W.S. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: The heart and soul study Circ. Cardiovasc. Qual. Outcomes 2010 3 406 412 10.1161/CIRCOUTCOMES.109.896159 20551373
50. Amin A.A. Menon R.A. Reid K.J. Harris W.S. Spertus J.A. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels Psychosom. Med. 2008 70 856 862 10.1097/PSY.0b013e318188a01e 18842751
51. Pottala J.V. Churchill S.W. Talley J.A. Lynch D.A. von Schacky C. Harris W.S. Red blood cell fatty acids are associated with depression in a case-control study of adolescents Prostaglandins Leukot. Essent. Fatty Acids 2012 86 161 165 10.1016/j.plefa.2012.03.002 22464051
52. Ladesich J.B. Pottala J.V. Romaker A. Harris W.S. Membrane levels of omega-3 docosahexaenoic acid is associated with obstructive sleep apnea J. Clin. Sleep Med. 2011 7 391 396 21897776
53. Park Y. Lim J. Lee J. Kim S.G. Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction Br. J. Nutr. 2009 102 1355 1356 10.1017/S0007114509990298 19505347
54. Park Y. Park S. Yi H. Kim H.Y. Kang S.J. Kim J. Ahn H. Low level of n -3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans Nutr. Res. 2009 29 825 830 10.1016/j.nutres.2009.10.018 19963154
55. Son Y.K. Lee S.M. Kim S.E. Kim K.H. Lee S.Y. Bae H.R. Han J.Y. Park Y. An W.S. Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients J. Ren. Nutr. 2012 22 58 66 10.1053/j.jrn.2011.01.023 21620727
56. An W.S. Kim S.E. Kim K.H. Lee S. Park Y. Kim H.J. Vaziri N.D. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients J. Ren. Nutr. 2009 19 267 274 10.1053/j.jrn.2009.01.027 19539181
57. Oh J.S. Kim S.M. Sin Y.H. Kim J.K. Park Y. Bae H.R. Son Y.K. Nam H.K. Kang H.J. An W.S. Comparison of erythrocyte membrane fatty acid contents in renal transplant recipients and dialysis patients Transplant. Proc. 2012 44 2932 2935 10.1016/j.transproceed.2012.04.041 23195000
58. Harris W.S. Varvel S.A. Pottala J.V. Warnick G.R. McConnell J.P. The comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility J. Clin. Lipidol. 2013 7 433 440 10.1016/j.jacl.2013.05.001 24079284
59. Shearer G.C. Chen J. Chen Y. Harris W.S. Myocardial infarction does not affect fatty acid profiles in rats Prostaglandins Leukot. Essent. Fatty Acids 2009 81 411 416 10.1016/j.plefa.2009.08.002 19775878
60. Aarsetøy H. Aarsetøy R. Lindner T. Staines H. Harris W.S. Nilsen D.W.T. Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase Lipids 2011 46 151 161 10.1007/s11745-010-3511-3 21234696
61. Flock M.R. Skulas-Ray A.C. Harris W.S. Etherton T.D. Fleming J.A. Kris-Etherton P.M. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: A dose-response randomized controlled trial J. Am. Heart Assoc. 2013 2 e000513 10.1161/JAHA.113.000513 24252845
62. Ebbesson S.O. Devereux R.B. Cole S. Ebbesson L.O. Fabsitz R.R. Haack K. Harris W.S. Howard W.J. Laston S. Lopez-Alvarenga J.C. Heart rate is associated with red blood cell fatty acid concentration: The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) Study Am. Heart J. 2010 159 1020 1025 10.1016/j.ahj.2010.03.001 20569715
63. Harris W.S. Pottala J.V. Lacey S.M. Vasan R.S. Larson M.G. Robins S.J. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study Atherosclerosis 2012 225 425 431 22727409
64. Cohen B.E. Garg S.K. Ali S. Harris W.S. Whooley M.A. Red blood cell EPA and DHA concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: Data from the Heart and Soul Study J. Nutr. 2008 138 1135 1140 18492846
65. Block R.C. Harris W.S. Pottala J.V. Determinants of blood cell omega-3 fatty acid content Open Biomark. J. 2008 1 1 6 10.2174/1875318300801010001 19953197
66. Farzaneh-Far R. Harris W.S. Garg S. Na B. Whooley M.A. Inverse association of erythrocyte n -3 fatty acid levels with inflammatory biomarkers in stable coronary artery disease: The Heart and Soul Study Atherosclerosis 2009 205 538 543 19185299
67. An W.S. Son Y.K. Kim S.E. Kim K.H. Bae H.R. Lee S. Park Y. Kim H.J. Vaziri N.D. Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients Clin. Nephrol. 2011 75 195 203 10.5414/CNP75195 21329629
68. Salisbury A.C. Amin A.P. Harris W.S. Chan P.S. Gosch K.L. Rich M.W. O’Keefe J.H. Jr. Spertus J.A. Predictors of omega-3 index in patients with acute myocardial infarction Mayo Clin. Proc. 2011 86 626 632 10.4065/mcp.2011.0005 21719619
69. Jo S. An W.S. Park Y. Erythrocyte n -3 polyunsaturated fatty acids and the risk of type 2 diabetes in Koreans: A case-control study Ann. Nutr. Metab. 2013 63 283 290 24334969
70. Park Y. Kim M. Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n -3 PUFA but not risk of CVD Br. J. Nutr. 2011 106 1529 1534 10.1017/S0007114511001930 21736802
71. Grenon S.M. Conte M.S. Nosova E. Alley H. Chong K. Harris W.S. Vittinghoff E. Owens C.D. Association between n -3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease J. Vasc. Surg. 2013 58 1283 1290 10.1016/j.jvs.2013.05.024 23830313
72. Harris W.S. Poston W.C. Haddock C.K. Tissue n -3 and n -6 fatty acids and risk for coronary heart disease events Atherosclerosis 2007 193 1 10 10.1016/j.atherosclerosis.2007.03.018 17507020
73. Superko H.R. Superko S.M. Nasir K. Agatston A. Garrett B.C. Omega-3 fatty acid blood levels: Clinical significance and controversy Circulation 2013 128 2154 2161 10.1161/CIRCULATIONAHA.113.002731 24190935
74. Harris W.S. Kennedy K.F. O’Keefe J.H. Jr. Spertus J.A. Red blood cell fatty acid levels improve GRACE score prediction of 2-year mortality in patients with myocardial infarction Int. J. Cardiol. 2013 168 53 59 10.1016/j.ijcard.2012.09.076 23044429
75. Shearer G.C. Pottala J.V. Spertus J.A. Harris W.S. Red blood cell fatty acid patterns and acute coronary syndrome PLoS One 2009 4 e5444 19421317
76. Abuannadi M. O’Keefe J.H. Spertus J.A. Kennedy K.F. Harris W.S. Omega-3 Index: An Independent Predictor of 1 Year All Cause Mortality in Myocardial Infarction (MI) Patients Poster 174,AHA QCOR Meeting 19–21 May 2010 Available online: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_319392.pdf (accessed on 15 January 2014)
77. Aarsetoey H. Pönitz V. Grundt H. Staines H. Harris W.S. Nilsen D.W. ( n -3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome J. Nutr. 2009 139 507 513 10.3945/jn.108.096446 19158216
78. Harris W.S. Reid K.J. Sands S.A. Spertus J.A. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients Am. J. Cardiol. 2007 99 154 158 10.1016/j.amjcard.2006.08.013 17223410
79. Block R.C. Harris W.S. Reid K.J. Sands S.A. Spertus J.A. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls Atherosclerosis 2008 197 821 828 17875307
80. Kim Y.J. Jeong D.W. Lee J.G. Lee H.C. Lee S.Y. Kim Y.J. Yi Y.H. Park Y.S. Cho Y.H. Bae M.J. Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: A case-control study in Korea Lipids Health Dis. 2012 11 43 10.1186/1476-511X-11-43 22448615
81. Harris W.S. Gonzales M. Laney N. Sastre A. Borkon A.M. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients Am. J. Cardiol. 2006 98 1393 1395 17134636
82. Harris W.S. Pottala J.V. Sands S.A. Jones P.G. Comparison of the effects of fish and fish oil capsules on the n-3 fatty acid content of blood cells and plasma phospholipids Am. J. Clin. Nutr. 2007 86 1621 1625 18065578
83. Larson M.K. Ashmore J.H. Harris K.A. Vogelaar J.L. Pottala J.V. Sprehe M. Harris W.S. Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects Thromb. Haemost. 2008 100 634 641 18841286
84. Carney R.M. Freedland K.E. Stein P.K. Steinmeyer B.C. Harris W.S. Rubin E.H. Krone R.J. Rich M.W. Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease Psychosom. Med. 2010 72 748 754 10.1097/PSY.0b013e3181eff148 20716712
85. Skulas-Ray A.C. Kris-Etherton P.M. Harris W.S. Vanden Heuvel J.P. Wagner P.R. West S.G. Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy people with moderate hypertriglyceridemia Am. J. Clin. Nutr. 2011 93 243 252 10.3945/ajcn.110.003871 21159789
86. Schuchardt J.P. Neubronner J. Kressel G. Merkel A. von Schacky C. Hahn A. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial Prostaglandins Leukot. Essent. Fatty Acids 2011 85 381 386 10.1016/j.plefa.2011.07.006 21862301
87. Dewell A. Marvasti F.F. Harris W.S. Tsao P. Gardner C.D. Dose-dependent effects of plant and marine omega-3 fatty acids on inflammatory markers in insulin resistant adults. A randomized controlled trial J. Nutr. 2011 141 2166 2171 10.3945/jn.111.142240 22031659
88. Maki K.C. Bays H.E. Dicklin M.R. Johnson S.L. Shabbout M. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia J. Clin. Lipidol. 2011 5 483 492 10.1016/j.jacl.2011.09.001 22108152
89. Krul E.S. Lemke S.L. Mukherjea R. Taylor M.L. Goldstein D.A. Su H. Liu P. Lawless A. Harris W.S. Maki K.C. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content Prostaglandins Leukot. Essent. Fatty Acids 2012 86 51 59 10.1016/j.plefa.2011.10.005 22064208
90. An W.S. Lee S.M. Son Y.K. Kim S.E. Kim K.H. Han J.Y. Bae H.R. Park Y. Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients Prostaglandins Leukot. Essent, Fatty Acids. 2012 86 29 34 22071008
91. Shearer G.C. Pottala J.V. Hansen S.N. Brandenburg V. Harris W.S. Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: A randomized controlled trial J. Lipid Res. 2012 53 2429 2435 10.1194/jlr.P022392 22892157
92. Skulas-Ray A.C. Kris-Etherton P.M. Harris W.S. West S.G. Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: A dose-response study Ann. Behav. Med. 2012 44 301 308 22865498
93. Keenan A.H. Pedersen T.L. Fillaus K. Larson M.K. Shearer G.C. Newman J.W. Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n -3-HUFA in healthy volunteers J. Lipid Res. 2012 53 1662 1669 10.1194/jlr.P025577 22628615
94. Block R.C. Dier U. Calderonartero P. Shearer G.C. Kakinami L. Larson M.K. Harris W.S. Georas S. Mousa S.A. The effects of EPA + DHA and aspirin on inflammatory cytokines and angiogenesis factors World J. Cardiovasc. Dis. 2012 2 14 19 22530200
95. Von Schacky C. Angerer P. Kothny W. Theisen K. Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind placebo-controlled trial Ann. Int. Med. 1999 130 554 562 10.7326/0003-4819-130-7-199904060-00003 10189324
96. Schuchardt J.P. Hahn A. Bioavailability of long-chain omega-3 fatty acids Prostaglandins Leukot. Essent. Fatty Acids 2013 89 1 8 10.1016/j.plefa.2013.03.010 23676322
97. Dyerberg J. Madsen P. Møller J.M. Aardestrup I. Schmidt E.B. Bioavailability of marine n -3 fatty acid formulations Prostaglandins Leukot. Essent. Fatty Acids 2010 83 137 141 10.1016/j.plefa.2010.06.007 20638827
98. Davidson M.H. Johnson J. Rooney M.W. Kyle M.L. Kling D.F. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova ® compared to Lovaza ® in a pharmacokinetic single-dose evaluation) study J. Clin. Lipidol. 2012 6 573 584 10.1016/j.jacl.2012.01.002 23312053
99. Hussey E.K. Portelli S. Fossler M.J. Gao F. Harris W.S. Blum R.A. Lates C.D. Gould E. Abu-Baker O. Johnson S. Relative bioavailability of an emulsion formulation for omega-3-acid ethyl esters compared to the commercially available formulation: A randomized, parallel-group, single-dose study followed by repeat dosing in healthy volunteers Clin. Pharm. Drug Dev. 2012 1 14 23 10.1177/2160763X11431107
100. Makrides M. Gibson R.A. McPhee A.J. Yelland L. Quinlivan J. Ryan P. DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial J. Am. Med. Assoc. 2010 304 1675 1683 10.1001/jama.2010.1507
101. Montgomery P. Burton J.R. Sewell R.P. Spreckelsen T.F. Richardson A.J. Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: A cross-sectional analysis from the DOLAB study PLoS One 2013 8 e66697 23826114
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.